Table of Content


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Mode of Delivery
3.3. Snippet by Component
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising clinical trials will drive the market growth
4.1.1.2. Investments and strategies by the key players
4.1.2. Restraints
4.1.2.1. Lack of skilled professionals
4.1.3. Opportunity
4.1.3.1. The adoption of Electronic Data Capture (EDC) systems and eClinical solutions
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario before COVID-19
6.1.2. Scenario during COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Impact Analysis
9. By Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.2. Market Attractiveness Index, By Type
9.2. On-Site CTMS
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Enterprise-wide CTMS
10. By Mode of Delivery
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
10.1.2. Market Attractiveness Index, By Mode of Delivery
10.2. Web-based
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. On-premise
10.4. Cloud-based
11. By Component
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.1.2. Market Attractiveness Index, By Component
11.2. Software
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Services
12. By End User
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.1.2. Market Attractiveness Index, By End User
12.2. Pharmaceuticals & Biotechnology Companies
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. CROs
12.4. Research Hospitals
12.5. Others
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. The U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. The U.K.
13.3.7.3. France
13.3.7.4. Italy
13.3.7.5. Spain
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. China
13.5.7.2. India
13.5.7.3. Japan
13.5.7.4. Australia
13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Market Share Analysis
14.3. Mergers and Acquisitions Analysis
15. Company Profiles
15.1. Oracle
15.1.1. Company Overview
15.1.2. Type Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. IQVIA Inc.
15.3. RealTime Software Solutions, LLC
15.4. Bio-Optronics
15.5. Medidata (Dassault Systemes)
15.6. BioClinica
15.7. Clario
15.8. Forte Research Systems
15.9. SimpleTrials
15.10. Calyx.
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Services
16.2. Contact Us